Akums Drugs & Pharmaceuticals Ltd.
647.35-3.3 (-0.50%)
8 Jul, 12:00 AM
Income Statement
Abridged
Understanding Income Statement
Akums Drugs & Pharmaceuticals Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Akums Drugs & Pharmaceuticals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Akums Drugs & Pharmaceuticals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
Business Segment Analysis
FY End:
Mar 26
Akums Drugs & Pharmaceuticals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
Revenue / Sales
Contract Development and Manufacturing Operations (CDMO) (78.2%)₹ 3,485.20 CrDomestic Branded formulations (10.0%)₹ 446.30 CrActive Pharmaceutical Ingredient (API) (4.1%)₹ 184.44 CrInternational Branded Formulations (3.2%)₹ 143.46 CrBranded and Generic formulations (2.3%)₹ 100.34 CrTrade generics (net) (2.2%)₹ 99.62 Cr
Assets
Contract Development and Manufacturing Operations (CDMO) (55.1%)₹ 3,054.40 CrUn allocated corporate assets or liabilities (33.8%)₹ 1,871.64 CrActive Pharmaceutical Ingredient (API) (7.2%)₹ 396.95 CrInternational Branded Formulations (1.7%)₹ 92.94 CrDomestic Branded formulations (1.4%)₹ 77.05 CrTrade generics (net) (0.8%)₹ 45.68 Cr
Regional Segment Analysis
FY End:
Mar 24
Akums Drugs & Pharmaceuticals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
Revenue / Sales
India (47.0%)₹ 3,908.57 CrIndia (47.0%)₹ 3,908.57 CrIreland (1.5%)₹ 125.41 CrIreland (1.5%)₹ 125.41 CrPhilippines (0.2%)₹ 15.69 CrPhilippines (0.2%)₹ 15.69 CrVietnam (0.1%)₹ 11.33 CrCambodia (0.1%)₹ 9.91 CrCambodia (0.1%)₹ 9.91 CrZambia (0.1%)₹ 8.47 CrZambia (0.1%)₹ 8.47 CrUganda (0.1%)₹ 7.25 CrPakistan (0.1%)₹ 6.90 CrPakistan (0.1%)₹ 6.90 CrNigeria (0.1%)₹ 6.80 CrMalawi (0.1%)₹ 5.80 CrJordan (0.1%)₹ 5.07 CrJordan (0.1%)₹ 5.07 CrNepal (0.1%)₹ 4.95 CrMyanmar (0.1%)₹ 4.91 CrMyanmar (0.1%)₹ 4.91 CrKenya (0.1%)₹ 4.80 CrKenya (0.1%)₹ 4.80 CrFrance (0.0%)₹ 3.95 CrFrance (0.0%)₹ 3.95 CrBangladesh (0.0%)₹ 3.86 CrBangladesh (0.0%)₹ 3.86 CrSri Lanka (0.0%)₹ 3.42 CrSri Lanka (0.0%)₹ 3.42 CrPeru (0.0%)₹ 3.37 CrPeru (0.0%)₹ 3.37 CrTanzania (0.0%)₹ 3.17 CrTanzania (0.0%)₹ 3.17 CrYemen (0.0%)₹ 3.08 CrYemen (0.0%)₹ 3.08 CrUzbekistan (0.0%)₹ 2.98 CrUzbekistan (0.0%)₹ 2.98 CrRwanda (0.0%)₹ 2.92 CrRwanda (0.0%)₹ 2.92 CrIndonesia (0.0%)₹ 2.73 CrIndonesia (0.0%)₹ 2.73 CrIraq (0.0%)₹ 2.28 CrIraq (0.0%)₹ 2.28 CrTurkmenistan (0.0%)₹ 2.14 CrTurkmenistan (0.0%)₹ 2.14 CrEthiopia (0.0%)₹ 1.92 CrEthiopia (0.0%)₹ 1.92 CrPanama (0.0%)₹ 1.83 CrPanama (0.0%)₹ 1.83 CrSaudi Arabia (0.0%)₹ 1.61 CrSaudi Arabia (0.0%)₹ 1.61 CrGhana (0.0%)₹ 1.57 CrGhana (0.0%)₹ 1.57 CrTurkey (0.0%)₹ 1.50 CrTurkey (0.0%)₹ 1.50 CrZimbabwe (0.0%)₹ 1.02 CrZimbabwe (0.0%)₹ 1.02 CrBurundi (0.0%)₹ 0.96 CrBurundi (0.0%)₹ 0.96 CrHong Kong (0.0%)₹ 0.89 CrHong Kong (0.0%)₹ 0.89 CrKyrgyzstan (0.0%)₹ 0.86 CrKyrgyzstan (0.0%)₹ 0.86 CrUnited Arab Emirates (0.0%)₹ 0.78 CrAfghanistan (0.0%)₹ 0.77 CrAfghanistan (0.0%)₹ 0.77 CrNamibia (0.0%)₹ 0.68 CrVenezuela (0.0%)₹ 0.51 CrVenezuela (0.0%)₹ 0.51 CrBhutan (0.0%)₹ 0.49 CrBhutan (0.0%)₹ 0.49 CrSingapore (0.0%)₹ 0.42 CrEcuador (0.0%)₹ 0.39 CrEcuador (0.0%)₹ 0.39 CrBotswana (0.0%)₹ 0.35 CrBotswana (0.0%)₹ 0.35 CrLebanon (0.0%)₹ 0.32 CrLebanon (0.0%)₹ 0.32 CrJamaica (0.0%)₹ 0.32 CrJamaica (0.0%)₹ 0.32 CrBrunei Darussalam (0.0%)₹ 0.24 CrCosta Rica (0.0%)₹ 0.22 CrSyria (0.0%)₹ 0.17 CrSyria (0.0%)₹ 0.17 CrTajikistan (0.0%)₹ 0.11 CrGeorgia (0.0%)₹ 0.10 CrGeorgia (0.0%)₹ 0.10 CrKazakhstan (0.0%)₹ 0.09 CrKazakhstan (0.0%)₹ 0.09 CrGuyana (0.0%)₹ 0.09 CrGermany (0.0%)₹ 0.08 CrGermany (0.0%)₹ 0.08 CrHonduras (0.0%)₹ 0.08 CrHonduras (0.0%)₹ 0.08 CrJapan (0.0%)₹ 0.05 CrJapan (0.0%)₹ 0.05 CrChina (0.0%)₹ 0.02 CrChina (0.0%)₹ 0.02 Cr
Historical Segment Analysis
Track how Akums Drugs & Pharmaceuticals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
Business
We don't have enough data to show the Capex for Akums Drugs & Pharmaceuticals Ltd..
Frequently Asked Questions
What is the revenue of Akums Drugs & Pharmaceuticals Ltd.?
The latest trailing twelve month revenue of Akums Drugs & Pharmaceuticals Ltd. is ₹ 4,359.02 Cr, reflecting a 1-year growth of 5.85% and a 3-year CAGR of 6.05%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Akums Drugs & Pharmaceuticals Ltd.?
The latest trailing twelve month net profit (PAT) of Akums Drugs & Pharmaceuticals Ltd. is ₹ 255.19 Cr, with a 3-year earnings CAGR of 40.37%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Akums Drugs & Pharmaceuticals Ltd.?
The trailing twelve month EBITDA of Akums Drugs & Pharmaceuticals Ltd. is approximately ₹ 367.47 Cr (based on an operating margin of 8.43%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Akums Drugs & Pharmaceuticals Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Akums Drugs & Pharmaceuticals Ltd. is 16.67. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Akums Drugs & Pharmaceuticals Ltd.?
The debt-to-equity ratio of Akums Drugs & Pharmaceuticals Ltd. stands at 0.05. The interest coverage ratio is 3.91x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Akums Drugs & Pharmaceuticals Ltd.?
The estimated book value per share of Akums Drugs & Pharmaceuticals Ltd. is 216.41 (derived from a P/B ratio of 2.99 and market price of ₹ 647.35), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Akums Drugs & Pharmaceuticals Ltd.?
The trailing twelve month operating cash flow of Akums Drugs & Pharmaceuticals Ltd. is ₹ 1,203.81 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Akums Drugs & Pharmaceuticals Ltd. report consolidated or standalone financials?
Akums Drugs & Pharmaceuticals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.